Document is current
Any future updates will be listed below
-
Authors
Kral, Pavol https://orcid.org/0000-0003-2723-7529
Holst-Hansen, Thomas
Olivieri, Anamaria V. https://orcid.org/0000-0002-0947-3002
Ivanescu, Cristina
Lamotte, Mark
Larsen, Sara https://orcid.org/0000-0002-3887-4948
-
Funding
Funding for this research was provided by:
Novo Nordisk A/S
- License Information
-
More Information
Article History
Received: 12 April 2024
Accepted: 14 June 2024
First Online: 24 September 2024
Declarations
:
: IQVIA, the employer of Pavol Kral, Anamaria V. Olivieri, Cristina Ivanescu and previous employer of Mark Lamotte, received consulting fees from Novo Nordisk A/S for conducting the analyses reported in this manuscript. Thomas Holst-Hansen and Sara Larsen are full-time employees of Novo Nordisk A/S. At the time of manuscript submission, Mark Lamotte was an independent consultant with no conflict of interest and his current affiliation is Th(is)<sup>2</sup>Modeling, Belgium.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
